577 related articles for article (PubMed ID: 12915689)
1. Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor.
Bourdeau I; Lacroix A; Schürch W; Caron P; Antakly T; Stratakis CA
J Clin Endocrinol Metab; 2003 Aug; 88(8):3931-7. PubMed ID: 12915689
[TBL] [Abstract][Full Text] [Related]
2. Vasopressin responsiveness of subclinical Cushing's syndrome due to ACTH-independent macronodular adrenocortical hyperplasia.
Tatsuno I; Uchida D; Tanaka T; Koide H; Shigeta A; Ichikawa T; Sasano H; Saito Y
Clin Endocrinol (Oxf); 2004 Feb; 60(2):192-200. PubMed ID: 14725680
[TBL] [Abstract][Full Text] [Related]
3. The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.
Louiset E; Stratakis CA; Perraudin V; Griffin KJ; Libé R; Cabrol S; Fève B; Young J; Groussin L; Bertherat J; Lefebvre H
J Clin Endocrinol Metab; 2009 Jul; 94(7):2406-13. PubMed ID: 19383776
[TBL] [Abstract][Full Text] [Related]
4. Mutations of the PRKAR1A gene in Cushing's syndrome due to sporadic primary pigmented nodular adrenocortical disease.
Groussin L; Jullian E; Perlemoine K; Louvel A; Leheup B; Luton JP; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2002 Sep; 87(9):4324-9. PubMed ID: 12213893
[TBL] [Abstract][Full Text] [Related]
5. Bilateral adrenal Cushing's syndrome: macronodular adrenal hyperplasia and primary pigmented nodular adrenocortical disease.
Lacroix A; Bourdeau I
Endocrinol Metab Clin North Am; 2005 Jun; 34(2):441-58, x. PubMed ID: 15850852
[TBL] [Abstract][Full Text] [Related]
6. Synaptophysin immunoreactivity in primary pigmented nodular adrenocortical disease: neuroendocrine properties of tumors associated with Carney complex.
Stratakis CA; Carney JA; Kirschner LS; Willenberg HS; Brauer S; Ehrhart-Bornstein M; Bornstein SR
J Clin Endocrinol Metab; 1999 Mar; 84(3):1122-8. PubMed ID: 10084605
[TBL] [Abstract][Full Text] [Related]
7. Use of 3-Dimensional Volumetric Modeling of Adrenal Gland Size in Patients with Primary Pigmented Nodular Adrenocortical Disease.
Chrysostomou PP; Lodish MB; Turkbey EB; Papadakis GZ; Stratakis CA
Horm Metab Res; 2016 Apr; 48(4):242-6. PubMed ID: 27065461
[TBL] [Abstract][Full Text] [Related]
8. Detection of somatic beta-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD).
Tadjine M; Lampron A; Ouadi L; Horvath A; Stratakis CA; Bourdeau I
Clin Endocrinol (Oxf); 2008 Sep; 69(3):367-73. PubMed ID: 18419788
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib reduces glucocorticoids in vitro and in a mouse model with adrenocortical hyperplasia.
Liu S; Saloustros E; Berthon A; Starost MF; Sahut-Barnola I; Salpea P; Szarek E; Faucz FR; Martinez A; Stratakis CA
Endocr Relat Cancer; 2016 Jan; 23(1):15-25. PubMed ID: 26438728
[TBL] [Abstract][Full Text] [Related]
10. The human homolog of Diminuto/Dwarf1 gene (hDiminuto): a novel ACTH-responsive gene overexpressed in benign cortisol-producing adrenocortical adenomas.
Sarkar D; Imai T; Kambe F; Shibata A; Ohmori S; Siddiq A; Hayasaka S; Funahashi H; Seo H
J Clin Endocrinol Metab; 2001 Nov; 86(11):5130-7. PubMed ID: 11701665
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of dexamethasone suppression test during the diagnosis of primary pigmented nodular adrenocortical disease in Chinese adrenocorticotropic hormone-independent Cushing syndrome.
Chen S; Li R; Lu L; Duan L; Zhang X; Tong A; Pan H; Zhu H; Lu Z
Endocrine; 2018 Jan; 59(1):183-190. PubMed ID: 29094256
[TBL] [Abstract][Full Text] [Related]
12. Systematic analysis of G protein-coupled receptor gene expression in adrenocorticotropin-independent macronodular adrenocortical hyperplasia identifies novel targets for pharmacological control of adrenal Cushing's syndrome.
Assie G; Louiset E; Sturm N; René-Corail F; Groussin L; Bertherat J; Thomas M; Lefebvre H; Feige JJ; Clauser E; Chabre O; Cherradi N
J Clin Endocrinol Metab; 2010 Oct; 95(10):E253-62. PubMed ID: 20660048
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol Biosynthesis and Trafficking in Cortisol-Producing Lesions of the Adrenal Cortex.
London E; Wassif CA; Horvath A; Tatsi C; Angelousi A; Karageorgiadis AS; Porter FD; Stratakis CA
J Clin Endocrinol Metab; 2015 Oct; 100(10):3660-7. PubMed ID: 26204136
[TBL] [Abstract][Full Text] [Related]
14. Clinical and genetic heterogeneity, overlap with other tumor syndromes, and atypical glucocorticoid hormone secretion in adrenocorticotropin-independent macronodular adrenal hyperplasia compared with other adrenocortical tumors.
Hsiao HP; Kirschner LS; Bourdeau I; Keil MF; Boikos SA; Verma S; Robinson-White AJ; Nesterova M; Lacroix A; Stratakis CA
J Clin Endocrinol Metab; 2009 Aug; 94(8):2930-7. PubMed ID: 19509103
[TBL] [Abstract][Full Text] [Related]
15. Cellular and molecular abnormalities of a macronodular adrenal hyperplasia causing beta-blocker-sensitive Cushing's syndrome.
Mazzuco TL; Thomas M; Martinie M; Cherradi N; Sturm N; Feige JJ; Chabre O
Arq Bras Endocrinol Metabol; 2007 Dec; 51(9):1452-62. PubMed ID: 18209887
[TBL] [Abstract][Full Text] [Related]
16. Autocrine positive regulatory feedback of glucocorticoid secretion: glucocorticoid receptor directly impacts H295R human adrenocortical cell function.
Asser L; Hescot S; Viengchareun S; Delemer B; Trabado S; Lombès M
Mol Cell Endocrinol; 2014 Sep; 395(1-2):1-9. PubMed ID: 25058354
[TBL] [Abstract][Full Text] [Related]
17. Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease.
de Cremoux P; Rosenberg D; Goussard J; Brémont-Weil C; Tissier F; Tran-Perennou C; Groussin L; Bertagna X; Bertherat J; Raffin-Sanson ML
Endocr Relat Cancer; 2008 Jun; 15(2):465-74. PubMed ID: 18508999
[TBL] [Abstract][Full Text] [Related]
18. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
19. Regulation of steroidogenesis in a primary pigmented nodular adrenocortical disease-associated adenoma leading to virilization and subclinical Cushing's syndrome.
Hofland J; de Herder WW; Derks L; Hofland LJ; van Koetsveld PM; de Krijger RR; van Nederveen FH; Horvath A; Stratakis CA; de Jong FH; Feelders RA
Eur J Endocrinol; 2013 Jan; 168(1):67-74. PubMed ID: 23065993
[TBL] [Abstract][Full Text] [Related]
20. Cyclical Cushing syndrome presenting in infancy: an early form of primary pigmented nodular adrenocortical disease, or a new entity?
Gunther DF; Bourdeau I; Matyakhina L; Cassarino D; Kleiner DE; Griffin K; Courkoutsakis N; Abu-Asab M; Tsokos M; Keil M; Carney JA; Stratakis CA
J Clin Endocrinol Metab; 2004 Jul; 89(7):3173-82. PubMed ID: 15240590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
